Evogene (EVGN) Tax Rate (2016 - 2026)

Evogene (EVGN) posted Tax Rate of 0.07% for Q1 2026, down 151.65% sequentially from 0.13% in Q4 2025.

Evogene (EVGN) Tax Rate (2016 - 2026) Analysis & Trends

Evogene has reported Tax Rate for 11 years, with the latest figure at 0.07% in Q1 2026.

Quarterly Tax Rate changed N/A year-over-year to 0.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (changed N/A YoY) and the FY2025 annual result came in at 0.04%, up 11.0% from the prior year.
Tax Rate fell to 0.07% in Q1 2026 per EVGN's latest filing, from 0.13% in the prior quarter.
Over five years, Tax Rate peaked at 0.71% in Q4 2024 and troughed at 1.19% in Q4 2022.
A 5-year average of 0.03% and a median of 0.02% in 2022 frame the typical range for Tax Rate.
The sharpest annual moves came in 2022 and 2023: Tax Rate tumbled 127 bps in 2022, then surged 125 bps in 2023.
Over 5 years, Tax Rate stood at 1.19% in 2022, then jumped by 105 bps to 0.05% in 2023, then surged by 1198 bps to 0.71% in 2024, then slumped by 81 bps to 0.13% in 2025, then sank by 152 bps to 0.07% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 0.07%, 0.13%, and 0.71% for Q1 2026, Q4 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	15.11%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	10.91%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	34.12%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Evogene	4.38 Mn	4.38 Mn	204,000.00	-0.07%

Download Data